A personalized prediction model for urinary tract infections in type 2 diabetes mellitus using machine learning
Article in Frontiers in Pharmacology (January 2024)
The most recent citing publications are shown below. View all 72 publications that cite this research output on Dimensions.
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI
Article in Science Translational Medicine (November 2023)
No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled, cross‐over trial (ENERGIZE)
Article in Diabetes Obesity and Metabolism (September 2023)